Psychiatry · Fairfax, VA
NPI
1336257278
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8221 Willow Oaks Corporate Dr
Fairfax, VA, 22031
Phone (703) 207-7819
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
282 services
Medicare patients, 2024
56
Average age 54
Drug cost, 2024
$1.1M
1,841 prescriptions
Company payments, 2025
$2,851
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Tsao was code 99214 (office e&m - established), 252 times for 42 patients. In total Maria Tsao billed 282 services in 3 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 252 | 42 | $69.64 | $18K |
| 96372 Injection Administration | Facility | 28 | 19 | $11.85 | $332 |
By year: 2022 $16K for 242 services; 2023 $19K for 255 services; 2024 $18K for 282 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Tsao prescribed most often to Medicare patients was Sertraline Hcl, with 141 prescriptions and refills. In total Maria Tsao wrote 1,841 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sertraline Hcl Generic | 141 | 219 | 23 | $1,124 |
| Olanzapine Generic | 127 | 179 | 18 | $12K |
| Quetiapine Fumarate Generic | 111 | 171 | 15 | $3,092 |
| Invega Sustenna Paliperidone Palmitate | 88 | 88 | 11 | $265K |
| Clozapine Generic | 75 | 75 | Under 11 | $9,361 |
| Fluoxetine Hcl Generic | 65 | 88 | Under 11 | $604 |
| Aripiprazole Generic | 60 | 94 | Under 11 | $15K |
| Duloxetine Hcl Generic | 59 | 61 | Under 11 | $1,001 |
| Clonazepam Generic | 58 | 80 | 11 | $496 |
| Risperidone Generic | 57 | 88 | Under 11 | $834 |
| Ziprasidone Hcl Generic | 53 | 87 | Under 11 | $3,026 |
| Vraylar Cariprazine Hcl | 52 | 52 | Under 11 | $78K |
| Lamotrigine Generic | 47 | 75 | Under 11 | $504 |
| Bupropion Xl Bupropion Hcl | 42 | 52 | Under 11 | $920 |
| Divalproex Sodium Generic | 41 | 53 | Under 11 | $2,126 |
Brand drugs: 318 claims; generic drugs: 1,523 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Tsao $2,851 ($2,851 in general payments such as food, travel and fees) from 10 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $596.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $596 |
| Vanda Pharmaceuticals Inc. VNDA | 11 | $477 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 15 | $419 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $309 |
| Neurocrine BioSciences, Inc. NBIX | 11 | $293 |
| Abbvie Inc. ABBV | 7 | $280 |
| Alkermes, Inc. ALKS | 7 | $170 |
| Janssen Pharmaceuticals, Inc JNJ | 5 | $150 |
| Axsome Therapeutics, Inc. AXSM | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $38.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.